Dementia in other diseases classified elsewhere

F5_DEMINOTH

obsolete_dementia: ['An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.']

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F02* Cause of death: ICD-10 — F02* 2 out of 7 registries used, show all original rules.	1652
4. Check minimum number of events None	1652
5. Include endpoints None	1652
6. Filter based on genotype QC (FinnGen only)	1652

Control definitions (FinnGen only)

Control exclude: F5_ORGANIC

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF3

NAME	F5_DEMINOTH
CONTROL_EXCLUDE	F5_ORGANIC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F02
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F02
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dementia in other diseases classified elsewhere based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	19287	9396	9701
Only index persons	16089	8004	8085
Unadjusted period prevalence (%)
Whole population	0.27	0.27	0.27
Only index persons	0.30	0.29	0.31
Median age at first event (years)
Whole population	75.14	75.93	74.35
Only index persons	74.85	75.59	74.11

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1652	752	900
Unadjusted period prevalence (%)	0.33	0.26	0.40
Median age at first event (years)	72.29	70.52	73.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1429: Matched controls
14290

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

71.2

323.0

634

158

N06DA03

ATC

rivastigmine; oral, transdermal

429.7

323.0

424

G20

ICD-10 Finland

Parkinson disease

68.4

323.0

671

182

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

59.7

323.0

687

218

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

8185.5

323.0

537

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

275.1

255

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

89.6

266.4

293

N04BD01

ATC

selegiline; oral

57.4

263.7

311

N87

ICPC

Parkinsonism

70.4

260.8

297

N05AH04

ATC

quetiapine; oral

9.9

235.3

542

834

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

191.0

179

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

+∞

189.9

178

G35

ICD-10 Finland

Multiple sclerosis

50.5

156.4

189

N04BC05

ATC

pramipexole; oral

8.3

144.7

355

550

N04BD02

ATC

rasagiline; oral

54.6

141.9

169

N06DX01

ATC

memantine; oral

64.2

138.0

160

N06DA02

ATC

donepezil; oral

55.0

132.0

157

109

Kela drug reimbursment

Multiple sclerosis

75.4

131.7

149

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

+∞

129.1

122

F03

ICD-10 Finland

Unspecified dementia

32.7

128.8

171

N04BC04

ATC

ropinirole; oral

37.9

126.4

162

G40.9

ICD-10 Finland

Epilepsy, unspecified

14.4

123.1

217

176

193

Kela drug reimbursment

Rasagiline

54.0

114.8

137

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

604.6

114.7

112

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

100.7

109.9

120

N03AE01

ATC

clonazepam; systemic

8.9

108.8

248

330

N04BX02

ATC

entacapone; oral

81.5

107.2

120

N05AX08

ATC

risperidone; systemic

8.4

105.8

250

352

N03AG01

ATC

valproic acid; systemic, rectal

9.9

101.6

216

253

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

125.6

88.1

AA1AD

NOMESCO Finland

CT of head and brain

3.4

86.6

573

2376

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

7.8

86.0

211

310

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.6

84.7

471

1700

R53

ICD-10 Finland

Malaise and fatigue

3.6

83.3

479

1773

N04BB01

ATC

amantadine; oral

19.0

82.9

129

N86

ICPC

Multiple sclerosis

54.6

81.6

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.1

81.6

643

2989

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

85.3

79.0

G31.0

ICD-10 Finland

Circumscribed brain atrophy

75.1

L03AB07

ATC

interferon beta-1a; parenteral

120.9

74.7

XA800

NOMESCO Finland

Neuropsychological investigation

11.7

74.3

142

133

F05.9

ICD-10 Finland

Delirium, unspecified

85.9

72.8

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.9

68.6

583

2764

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

5.8

67.4

207

407

A06AD11

ATC

lactulose; oral

3.3

65.2

406

1547

TAB00

NOMESCO Finland

Lumbar puncture

9.2

64.8

141

168

A28

ICPC

Limited function/disability NOS

3.2

62.3

400

1551

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.4

62.1

200

415

R56.8

ICD-10 Finland

Other and unspecified convulsions

6.7

58.9

159

263

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.6

57.6

221

552

L03AX13

ATC

glatiramer acetate; parenteral

74.2

56.6

N05AH03

ATC

olanzapine; systemic

7.3

55.1

138

205

P70

ICPC

Dementia

25.8

54.2

N05BA04

ATC

oxazepam; oral

2.8

53.9

445

2005

SPAT1215

SPAT

Assessment of need for medical rehabilitation

6.6

53.7

146

243

P20

ICPC

Memory disturbance

3.5

53.0

281

931

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.9

51.4

182

416

N06AB10

ATC

escitalopram; oral

3.2

50.8

304

1100

N06AX11

ATC

mirtazapine; oral

2.5

50.8

514

2586

R41.0

ICD-10 Finland

Disorientation, unspecified

7.4

49.7

123

179

SPAT1216

SPAT

Assessment of functional ability

2.9

49.5

356

1457

H02AA02

ATC

fludrocortisone; oral

21.3

49.2

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

17.5

49.1

N03AF02

ATC

oxcarbazepine; oral

8.1

48.2

112

148

I95.1

ICD-10 Finland

Orthostatic hypotension

5.9

47.4

140

259

F02.30

ICD-10 Finland

Dementia in Parkinson's disease without additional symptoms

+∞

47.1

G30.1

ICD-10 Finland

Alzheimer disease with late onset

12.3

46.7

SPAT1234

SPAT

Support of social functional capacity

4.8

46.6

165

376

G30.8

ICD-10 Finland

Other Alzheimer disease

37.7

45.7

SPAT1229

SPAT

Assessment of need for aid

3.7

45.3

221

679

N06AB04

ATC

citalopram; systemic

2.7

45.1

380

1701

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.1

44.8

187

501

N05BA06

ATC

lorazepam; systemic, sublingual

5.1

44.4

150

324

H46

ICD-10 Finland

Optic neuritis

27.2

43.6

N03AX14

ATC

levetiracetam; systemic

8.1

43.5

101

133

G40

ICD-10 Finland

Epilepsy

23.5

42.6

N29

ICPC

Neurological sympt/complt other

10.8

42.4

G04BD12

ATC

mirabegron; oral

3.2

42.2

249

881

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.9

41.9

300

1211

M03BX01

ATC

baclofen; systemic

11.5

41.7

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.9

41.7

295

1180

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

41.2

359

1629

N99

ICPC

Neurological disease other

16.5

40.2

XKD06

NOMESCO Finland

Physiologic investigation of micturition

6.6

40.1

107

173

R25.1

ICD-10 Finland

Tremor, unspecified

7.1

40.0

101

151

L28

ICPC

Limited function/disability (L)

2.6

39.9

344

1547

F02.09

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

+∞

39.8

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

53.9

39.7

N03AX09

ATC

lamotrigine; oral

7.0

39.5

101

154

SPAT1231

SPAT

Assessment of adjustments needed in living environment

7.4

39.2

137

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

23.3

39.0

N06AX16

ATC

venlafaxine; oral

3.4

39.0

209

687

L03AB08

ATC

interferon beta-1b; parenteral

140.6

38.9

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

9.2

38.9

N04BC09

ATC

rotigotine; transdermal

29.9

38.9

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.7

38.5

305

1303

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

9.4

38.3

N03AF01

ATC

carbamazepine; oral, rectal

4.6

37.8

140

332

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

6.1

37.6

106

184

W19

ICD-10 Finland

Unspecified fall

3.3

36.7

205

694

F02.89*E03.9

ICD-10 Finland

Dementia in hypothyroidism, acquired

+∞

36.6

S01.0

ICD-10 Finland

Open wound of scalp

3.5

36.3

184

578

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.5

36.0

322

1468

183

Kela drug reimbursment

Lamotrigin and topiramate

19.0

35.9

F02.89

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without information of additional symptoms

130.0

35.9

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

7.1

35.7

134

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.3

35.7

142

361

N05BA01

ATC

diazepam; systemic, rectal

2.8

35.6

263

1073

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

9.1

35.4

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

+∞

34.5

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.0

33.9

144

389

F01.9

ICD-10 Finland

Vascular dementia, unspecified

57.2

33.4

N04AA02

ATC

biperiden; systemic

9.4

33.3

164

Kela drug reimbursment

Fingolimod

65.0

33.2

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.6

32.6

160

488

F05.1

ICD-10 Finland

Delirium superimposed on dementia

+∞

32.4

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.3

32.2

176

584

N04BC02

ATC

pergolide; oral

323.9

32.0

S72.0

ICD-10 Finland

Fracture of neck of femur

4.0

31.3

134

364

U04

ICPC

Incontinence urine

4.3

31.3

121

299

SPAT1172

SPAT

Guidance concerning hydration

5.8

31.2

165

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

4.1

30.8

127

333

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

8.4

30.8

S06.0

ICD-10 Finland

Concussion

3.0

30.5

190

687

N04BC06

ATC

cabergoline; oral (dopamine agonists)

25.4

30.2

R1250

NOMESCO Finland

Evaluation of functional capability

8.7

30.2

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

51.2

29.5

353

Kela drug reimbursment

Cladribine and fingolimod

58.0

29.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

28.9

236

1011

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

28.4

462

2732

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

10.7

27.9

SPAT1245

SPAT

Provision of support and information to patient’s family members

4.2

27.7

111

284

Z75.5

ICD-10 Finland

Holiday relief care

12.0

27.3

F0230, G20

ICD-10 Finland

+∞

27.2

F0232, G20

ICD-10 Finland

+∞

27.2

SPAT1053

SPAT

Memory test

2.3

27.0

295

1464

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.8

26.8

119

333

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.9

26.6

177

667

F05.8

ICD-10 Finland

Other delirium

+∞

26.1

F06.7

ICD-10 Finland

Mild cognitive disorder

10.1

26.1

A04

ICPC

Weakness/tiredness general

2.5

26.1

235

1058

2AB04

NOMESCO Finland

74.1

25.9

R55

ICD-10 Finland

Syncope and collapse

2.5

25.4

224

996

N06AX21

ATC

duloxetine; oral

2.9

25.1

162

599

D21

ICPC

Swallowing problem

8.5

25.0

N19

ICPC

Speech disorder

8.5

24.5

SPAT1254

SPAT

Administration of medicine

2.3

24.0

261

1285

Z02.4

ICD-10 Finland

Examination for driving licence

0.4

24.0

124

2688

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

31.6

23.8

F02.80

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without additional symptoms

243.9

23.7

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.9

23.6

156

584

L04AA27

ATC

fingolimod; oral

47.5

23.4

3400A

ICD-9 Finland

Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]

47.5

23.4

SPAT1167

SPAT

Insertion of urinary catheter

3.9

23.3

262

TKC20

NOMESCO Finland

Catheterisation of bladder

2.7

23.1

168

668

F06.0

ICD-10 Finland

Organic hallucinosis

+∞

23.0

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

22.7

267

1359

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

11.0

22.7

G04BD09

ATC

trospium; oral

4.5

22.5

187

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.0

22.4

138

494

WYA20

NOMESCO Finland

Home visit

8.0

22.4

N30.0

ICD-10 Finland

Acute cystitis

2.3

22.1

227

1085

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.8

21.9

113

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

4.4

21.9

192

L04AA31

ATC

teriflunomide; oral

81.4

21.7

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.8

21.3

160

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

50.8

21.2

N03AX18

ATC

lacosamide; systemic

16.9

21.0

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

10.8

20.9

N05AH02

ATC

clozapine; systemic

9.8

20.9

F0280, G318

ICD-10 Finland

+∞

20.9

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

21.9

20.8

R35

ICD-10 Finland

Polyuria

2.9

20.8

133

488

N28

ICPC

Limited function/disability (N)

7.0

20.6

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

111.6

20.6

N88

ICPC

Epilepsy

18.6

20.4

XKD00

NOMESCO Finland

Uroflowmetry

2.0

20.2

312

1770

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

7.9

20.1

G02CB01

ATC

bromocriptine; systemic

9.0

19.9

N03AX16

ATC

pregabalin; oral

1.9

19.7

343

2035

R41.3

ICD-10 Finland

Other amnesia

5.1

19.6

129

N05AD01

ATC

haloperidol; systemic

4.1

19.4

191

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

31.8

19.3

XF606

NOMESCO Finland

Ortostatic test

11.2

19.2

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

10.5

19.2

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.8

19.2

223

N05CD07

ATC

temazepam; oral

2.1

18.8

244

1288

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

+∞

18.8

N02AA05

ATC

oxycodone; systemic

2.0

18.3

263

1449

G41.9

ICD-10 Finland

Status epilepticus, unspecified

11.2

18.2

G04BD07

ATC

tolterodine; oral

2.8

18.2

120

449

R44.1

ICD-10 Finland

Visual hallucinations

22.0

18.2

N30.9

ICD-10 Finland

Cystitis, unspecified

2.9

18.1

113

407

UKC02

NOMESCO Finland

Cystoscopy

1.9

18.0

302

1759

N03AX12

ATC

gabapentin; oral

2.1

17.9

234

1238

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

13.9

17.8

F0203, G310

ICD-10 Finland

+∞

17.7

J01EA01

ATC

trimethoprim; systemic

1.8

17.7

390

2491

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

10.5

17.7

R13

ICD-10 Finland

Dysphagia

2.8

17.7

121

464

G72.8

ICD-10 Finland

Other specified myopathies

5.9

17.6

L04AX07

ATC

dimethyl fumarate; oral

96.2

17.6

N02BE01

ATC

paracetamol; systemic, rectal

1.8

17.5

1159

10079

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

17.3

295

1726

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.4

17.2

159

716

P29

ICPC

Psychological sympt/compl other

4.1

17.2

173

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

4.9

17.1

118

F29

ICD-10 Finland

Unspecified nonorganic psychosis

5.4

17.0

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

16.9

249

1381

SPAT1360

SPAT

Extensive global examination

2.6

16.8

131

541

F02.89*A69.2

ICD-10 Finland

Dementia in Lyme disease

+∞

16.7

R32

ICD-10 Finland

Unspecified urinary incontinence

4.0

16.7

173

E86

ICD-10 Finland

Volume depletion

4.0

16.6

174

N03AB02

ATC

phenytoin; systemic

6.9

16.6

H48.1*G35

ICD-10 Finland

Retrobulbar neuritis in multiple sclerosis

171.9

16.5

N05BA09

ATC

clobazam; oral

20.3

16.4

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

6.8

16.4

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

16.3

232

1268

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

16.2

497

3481

J01CA08

ATC

pivmecillinam; oral

1.7

16.2

493

3443

G30.0

ICD-10 Finland

Alzheimer disease with early onset

48.1

16.0

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

16.0

120

483

N06DA04

ATC

galantamine; oral

24.8

16.0

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

15.8

335

G04BD11

ATC

fesoterodine; oral

3.6

15.8

208

G04BD04

ATC

oxybutynin; oral, transdermal

2.6

15.7

120

490

R4110

NOMESCO Finland

Physiotherapy

1.7

15.7

381

2492

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

13.1

15.7

G04BD08

ATC

solifenacin; oral

2.5

15.7

131

562

4AA23

NOMESCO Finland

+∞

15.6

F02.3

ICD-10 Finland

Dementia in Parkinson disease

+∞

15.6

F02.31

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly paranoidism

+∞

15.6

R33

ICD-10 Finland

Retention of urine

2.2

15.6

173

851

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.3

15.6

258

C07AA05

ATC

propranolol; systemic

1.9

15.5

234

1304

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.0

15.3

308

K59.0

ICD-10 Finland

Constipation

2.6

15.2

115

464

3320A

ICD-9 Finland

Parkinson's disease, Paralysis agitans

45.5

15.1

JDB10

NOMESCO Finland

Percutaneous gastrostomy

6.9

15.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

14.9

251

1455

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

16.7

14.8

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

6.4

14.6

F0029, G308

ICD-10 Finland

+∞

14.6

F02.34

ICD-10 Finland

Dementia in Parkinson's disease, other additional symptoms of mixed type

+∞

14.6

F0204, G310

ICD-10 Finland

+∞

14.6

F0289, G318

ICD-10 Finland

+∞

14.6

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.2

14.6

158

767

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.3

14.4

127

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

14.3

200

1081

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.3

14.3

123

F22.0

ICD-10 Finland

Delusional disorder

6.3

14.1

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

14.0

176

914

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

15.9

13.9

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.2

13.9

236

N07XX09

ATC

[U] dimethyl fumarate; oral

53.9

13.8

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

10.6

13.7

RT250

NOMESCO Finland

75.9

13.6

F02.8

ICD-10 Finland

Dementia in other specified diseases classified elsewhere

+∞

13.6

F0234, G20

ICD-10 Finland

+∞

13.6

F023, G20

ICD-10 Finland

+∞

13.6

F0200, G310

ICD-10 Finland

+∞

13.6

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

34.4

13.5

N05CF01

ATC

zopiclone; oral

1.6

13.4

484

3500

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

13.3

349

2317

I95.9

ICD-10 Finland

Hypotension, unspecified

5.2

13.2

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

16.9

13.0

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

12.9

216

1243

R47.1

ICD-10 Finland

Dysarthria and anarthria

7.8

12.9

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.6

12.9

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

12.9

172

914

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.9

12.7

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

3.9

12.6

134

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

12.5

223

1313

R42

ICD-10 Finland

Dizziness and giddiness

1.7

12.5

320

2105

F02.89*A52.1

ICD-10 Finland

Paralytic dementia

+∞

12.5

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

+∞

12.5

F02.89*M32.8

ICD-10 Finland

Dementia in systemic lupus erythematosus

+∞

12.5

IGY02

NOMESCO Finland

Psychiatric monitoring contact

7.4

12.5

F02.82

ICD-10 Finland

Dementia in other specified disease that is classified elsewhere other symptoms, mainly hallucinations

131.1

12.5

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

131.1

12.5

RS221

NOMESCO Finland

6.1

12.4

S01

ICD-10 Finland

Open wound of head

6.6

12.3

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

11.7

12.3

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

12.3

103

441

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

10.6

12.3

Z43.5

ICD-10 Finland

Attention to cystostomy

9.7

12.2

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

37.9

12.2

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

5.2

12.2

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

12.5

12.1

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

12.1

139

692

R4130

NOMESCO Finland

Speech therapy

3.8

12.1

134

K91

ICPC

Cerebrovascular disease

4.7

12.0

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

12.0

296

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

11.9

114

523

G04CA02

ATC

tamsulosin; oral

1.6

11.9

406

2878

R60.0

ICD-10 Finland

Localized oedema

1.9

11.8

180

1005

N06AX12

ATC

bupropion; oral

3.3

11.7

175

RT150

NOMESCO Finland

30.3

11.6

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

12.7

11.6

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

12.7

11.6

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

11.6

241

1490

N06BA07

ATC

modafinil; oral

23.1

11.6

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.4

11.5

161

N06AB06

ATC

sertraline; oral

2.2

11.5

117

553

F0019, G301

ICD-10 Finland

+∞

11.5

F02.89*M30.0

ICD-10 Finland

Dementia in polyarteritis nodosa

+∞

11.5

F02.00

ICD-10 Finland

Dementia in Pick's disease without additional symptoms

+∞

11.5

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

13.7

11.5

SPAT1125

SPAT

Stoma care and guidance

4.1

11.4

106

S70.0

ICD-10 Finland

Contusion of hip

2.8

11.4

264

P28

ICPC

Limited function/disability (P)

11.9

11.3

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.9

11.3

117

S00.0

ICD-10 Finland

Superficial injury of scalp

3.8

11.2

123

H50.52

ICD-10 Finland

Exophoria

11.2

11.1

Y94.0

ICD-10 Finland

Accident at home

4.0

11.0

110

C03CA01

ATC

furosemide; systemic

1.5

11.0

544

4179

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

7.5

11.0

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

10.9

147

780

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

10.9

112

531

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.7

10.7

281

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.7

10.6

SPAT1262

SPAT

Handing over of treatment supplies

1.7

10.6

259

1673

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

10.1

10.5

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

6.2

10.5

F0282, G318

ICD-10 Finland

+∞

10.4

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

+∞

10.4

F0009, G300

ICD-10 Finland

+∞

10.4

F009, G309

ICD-10 Finland

+∞

10.4

F02.89*E53.8

ICD-10 Finland

Dementia due to vitamin B12 deficiency

+∞

10.4

U13

ICPC

Bladder symptom/complaint other

3.2

10.4

169

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

7.8

10.4

34099

ICD-8 Finland

Multiple sclerosis

16.2

10.4

E000001

ATC

1.7

10.3

251

1621

L04AX01

ATC

azathioprine; systemic

2.9

10.3

231

F06.32

ICD-10 Finland

Organic depression

32.8

10.3

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

18.9

10.3

34599

ICD-8 Finland

Epilepsy, Other and unspecified

9.6

10.3

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

10.3

144

779

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

23.5

10.2

R1260

NOMESCO Finland

Evaluation of communicative skills

4.0

10.1

G04BD10

ATC

darifenacin; oral

7.0

10.1

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

10.1

548

4269

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.8

10.0

F06.4

ICD-10 Finland

Organic anxiety disorder

40.3

10.0

A29

ICPC

General symptom/complaint other

1.9

9.9

158

894

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

6.0

9.8

RS121

NOMESCO Finland

9.6

9.8

N06AX03

ATC

mianserin; oral

2.4

9.7

336

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

55.4

9.7

H03AA01

ATC

levothyroxine sodium; systemic

1.6

9.6

290

1978

J01DB01

ATC

cefalexin; oral

1.5

9.5

1019

9001

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

9.2

9.5

L76

ICPC

Fracture: other

3.1

9.5

164

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

9.5

295

2029

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

100.7

9.4

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

6.2

9.4

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.0

9.4

187

F0202, G310

ICD-10 Finland

+∞

9.4

N04BX01

ATC

tolcapone; oral

+∞

9.4

F02.29*G10

ICD-10 Finland

Dementia in Huntington's disease without information on additional symptoms

+∞

9.4

F02.04

ICD-10 Finland

Dementia in Pick's disease other additional symptoms of mixed type

+∞

9.4

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.6

9.3

G40.89

ICD-10 Finland

Other epilepsy

10.7

9.3

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

9.6

9.3

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

7.3

9.2

X58

ICD-10 Finland

Exposure to other specified factors

1.8

9.2

148

841

N05AB03

ATC

perphenazine; systemic, rectal

3.3

9.1

141

N05AA02

ATC

levomepromazine; systemic

2.7

9.1

233

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

7.1

9.0

RS222

NOMESCO Finland

4.9

9.0

F32

ICD-10 Finland

Depressive episode

3.0

8.9

175

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

7.5

8.9

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

18.7

8.9

F99

ICD-10 Finland

Mental disorder, not otherwise specified

4.8

8.9

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

8.8

345

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

10.8

8.8

TJD20

NOMESCO Finland

Change of gastrostomy tube

10.8

8.8

XKC03

NOMESCO Finland

Water cystometry

2.8

8.8

201

P76

ICPC

Depressive disorder

2.8

8.8

201

N05AX12

ATC

aripiprazole; systemic

3.7

8.8

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.5

8.7

278

N06AB03

ATC

fluoxetine; oral

1.8

8.7

139

790

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

5.5

8.6

R4120

NOMESCO Finland

Occupational therapy

2.2

8.6

400

N05AN01

ATC

lithium; oral

4.3

8.5

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

20.1

8.5

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

4.2

8.4

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

6.7

8.4

130

Kela drug reimbursment

Malignant tumour

0.4

8.4

855

F02.89*T58

ICD-10 Finland

Dementia with carbon monoxide intoxication

+∞

8.3

LAITO

NOMESCO Finland

+∞

8.3

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

+∞

8.3

F0201, G310

ICD-10 Finland

+∞

8.3

WX892

NOMESCO Finland

Monitored bed care

1.9

8.3

117

631

N03AX11

ATC

topiramate; oral

3.9

8.3

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.3

8.2

125

N06AX26

ATC

vortioxetine; oral

2.7

8.2

206

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

14.6

8.2

TKC22

NOMESCO Finland

Catheterisation instruction

3.1

8.2

142

S01.9

ICD-10 Finland

Open wound of head, part unspecified

3.6

8.2

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

7.6

8.2

T90.5

ICD-10 Finland

Sequelae of intracranial injury

6.1

8.2

R11

ICD-10 Finland

Nausea and vomiting

1.9

8.1

114

617

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

2.0

8.1

100

517

P03

ICPC

Feeling depressed

2.3

8.1

346

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.4

8.1

275

F50.9

ICD-10 Finland

Eating disorder, unspecified

17.3

8.1

SPAT1281

SPAT

Other administrative function

2.0

8.1

105

551

N06AA12

ATC

doxepin; systemic

2.2

8.0

395

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.7

8.0

203

G40.10

ICD-10 Finland

Simple partial seizures

6.3

8.0

K08.3

ICD-10 Finland

Retained dental root

2.1

8.0

460

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.4

8.0

112

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.5

7.9

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

7.9

130

744

Y07

ICD-10 Finland

Other maltreatment

10.9

7.8

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

7.8

133

773

N05BE01

ATC

buspirone; oral

3.2

7.7

120

34510

ICD-8 Finland

Epilepsy, """"Grand mal""""

15.1

7.7

ICD-10 Finland

3.1

7.7

132

N06AX05

ATC

trazodone; oral

3.7

7.7

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.7

7.6

192

EBA00

NOMESCO Finland

Extraction of tooth

1.5

7.6

348

2594

AA1AA

NOMESCO Finland

Head X-ray examination

5.4

7.5

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

10.1

7.5

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

4.3

7.5

J01MA02

ATC

ciprofloxacin; systemic

1.4

7.5

528

4252

N18

ICPC

Paralysis/weakness

3.3

7.5

107

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

3.8

7.5

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.5

7.5

241

G40.36

ICD-10 Finland

Juvenile myoclonic epilepsy [impulsive petit mal]

80.5

7.4

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

7.4

140

838

RF120

NOMESCO Finland

4.6

7.4

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

7.7

7.4

RF220

NOMESCO Finland

3.6

7.4

F34.1

ICD-10 Finland

Dysthymia

3.1

7.3

120

N03AG04

ATC

vigabatrin; oral

+∞

7.3

F06.30

ICD-10 Finland

Organic manic syndrome

+∞

7.3

H51.1

ICD-10 Finland

Convergence insufficiency and excess

+∞

7.3

F064, G310

ICD-10 Finland

+∞

7.3

K11.72

ICD-10 Finland

Xerostomia

+∞

7.3

F02.81

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere as additional symptoms, mainly paranoidism

+∞

7.3

R50.9

ICD-10 Finland

Fever, unspecified

1.6

7.3

182

1180

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

7.3

368

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

6.3

7.2

N30

ICD-10 Finland

Cystitis

2.0

7.1

483

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

5.1

7.1

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.5

7.1

247

1735

P99

ICPC

Psychological disorders other

3.8

7.1

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

7.1

531

R4150

NOMESCO Finland

Neuropsychological rehabilitation

8.8

7.0

S00

ICD-10 Finland

Superficial injury of head

8.8

7.0

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.8

7.0

152

J01MA12

ATC

levofloxacin; systemic

1.5

7.0

262

1870

N05AD03

ATC

melperone; systemic

4.0

7.0

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.1

6.9

114

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.9

6.9

S97

ICPC

Chronic ulcer skin

2.0

6.9

444

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

7.6

6.9

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

7.6

6.9

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

7.6

6.9

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.1

6.9

E87.6

ICD-10 Finland

Hypokalaemia

2.6

6.9

189

M05BA07

ATC

risedronic acid; oral

2.3

6.9

266

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.7

6.9

165

U07

ICPC

Urine symptom/complaint other

2.0

6.9

420

N05AF03

ATC

chlorprothixene; systemic

3.3

6.8

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

9.4

6.8

N06AX18

ATC

reboxetine; oral

5.3

6.8

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

5.7

6.8

G10

ICD-10 Finland

Huntington disease

40.2

6.8

G36.0

ICD-10 Finland

Neuromyelitis optica [Devic]

40.2

6.8

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

40.2

6.8

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

16.8

6.7

G30

ICD-10 Finland

Alzheimer disease

16.8

6.7

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.8

6.7

145

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

6.7

232

J01MA06

ATC

norfloxacin; oral

1.6

6.7

186

1238

N04AA01

ATC

trihexyphenidyl; oral

22.6

6.7

G21.8

ICD-10 Finland

Other secondary parkinsonism

22.6

6.7

A46

ICD-10 Finland

Erysipelas

1.6

6.7

199

1348

SPAT1251

SPAT

Organisation of medication

2.3

6.6

253

IGY99

NOMESCO Finland

Other psychiatric treatment contact

5.2

6.6

U28

ICPC

Limited function/disability (U)

4.6

6.6

D07AA02

ATC

hydrocortisone; topical

1.7

6.6

147

923

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

12.3

6.6

H47.2

ICD-10 Finland

Optic atrophy

10.1

6.5

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

4.2

6.5

N05BA12

ATC

alprazolam; oral

1.8

6.5

115

676

D12

ICPC

Constipation

2.4

6.5

222

N06AA09

ATC

amitriptyline; systemic

1.7

6.5

128

777

R44.3

ICD-10 Finland

Hallucinations, unspecified

7.4

6.4

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

14.4

6.4

K90

ICPC

Stroke/cerebrovascular accident

2.3

6.3

226

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

6.6

6.3

M05BA04

ATC

alendronic acid; oral

1.7

6.3

135

838

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.2

6.3

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.2

6.3

W06

ICD-10 Finland

Fall involving bed

5.5

6.3

WX730

NOMESCO Finland

Conventional respirator

3.0

6.3

111

KCJ00

NOMESCO Finland

Cystostomy

18.1

6.3

F00

ICD-10 Finland

Dementia in Alzheimer disease

18.1

6.3

F028, G318

ICD-10 Finland

+∞

6.3

F020, G310

ICD-10 Finland

+∞

6.3

F06.31

ICD-10 Finland

Organic bipolar syndrome

+∞

6.3

F06.33

ICD-10 Finland

Organic mood syndrome

+∞

6.3

F060, G310

ICD-10 Finland

+∞

6.3

NF3AA

NOMESCO Finland

Femur X-ray examination

3.1

6.2

106

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

26.8

6.2

N04BC01

ATC

bromocriptine; oral

26.8

6.2

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

6.2

318

2408

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

4.1

6.2

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.9

6.2

118

S06.3

ICD-10 Finland

Focal brain injury

3.8

6.2

K02.1

ICD-10 Finland

Caries of dentine

1.3

6.2

544

4504

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

6.2

302

C10AA07

ATC

rosuvastatin; oral

0.7

6.2

151

2190

XA400

NOMESCO Finland

EEG

5.8

6.1

G25.0

ICD-10 Finland

Essential tremor

2.6

6.1

160

R5110

SPAT

2.6

6.1

160

L75

ICPC

Fracture: femur

3.4

6.1

F41.3

ICD-10 Finland

Other mixed anxiety disorders

7.7

6.1

N05CF02

ATC

zolpidem; oral

1.5

6.1

187

1272

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.5

6.1

SCA03

NOMESCO Finland

Preventive oral health care, extensive

2.4

6.1

205

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.7

6.1

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

6.1

144

920

S22.3

ICD-10 Finland

Fracture of rib

1.9

6.1

471

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3009466) Valproate [Moles/volume] in Serum or Plasma

130

123

11.39

120.92

5.8

3.7

umol/l

351.3

355.0

0.08

104

108

(3019309) Folate [Moles/volume] in Red Blood Cells

604

2747

2.89

87.27

2.1

1.8

nmol/l

1112.1

1167.6

0.71

405

2023

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

10.89

54.37

1.0

ng/l

37.2

41.6

0.20

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

10.70

52.82

1.0

ng/l

284.6

279.8

0.03

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

10.70

52.82

1.0

ng/l

667.3

688.2

0.10

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

104

223

4.91

45.79

1.2

1.3

mg/l

502.1

542.9

0.37

213

(3044290) Cell count panel - Cerebral spinal fluid

174

5.35

43.54

1.2

—

(3026008) Bacteria identified in Urine by Culture

695

4358

2.03

41.05

5.1

3.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

199

4.89

41.01

1.2

mmol/l

3.6

3.9

2.31

183

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

656

4066

2.02

39.70

3.0

2.1

u/l

314.9

221.3

1.34

598

3785

(3023368) Bacteria identified in Blood by Culture

649

4022

2.01

39.16

5.3

4.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

197

4.72

37.67

1.2

1.3

e6/l

2.5

53.1

1.03

157

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

197

4.66

36.74

1.3

e6/l

92.8

796.1

0.70

162

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

440

2471

2.06

34.05

2.1

1.9

—

(3023410) Appearance of Cerebral spinal fluid

6.46

32.62

1.4

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

9.05

31.65

3.2

2.9

umol/l

29.7

31.4

0.29

(3031040) Bacteria [#/volume] in Urine by Automated count

1113

8631

1.89

31.05

8.2

4.9

e6/l

4599.2

1703.4

0.39

148

(3014271) Vancomycin [Susceptibility]

5.74

27.97

4.0

3.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

105

334

3.29

26.73

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

105

334

3.29

26.73

1.5

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

788

5678

1.74

26.29

2.6

2.1

pmol/l

87.6

93.4

3.08

452

2942

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

948

11519

0.58

24.06

3.9

4.6

mmol/l

1.4

0.27

777

10334

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

967

11630

0.59

22.56

3.9

4.7

mmol/l

4.4

0.36

796

10538

(3016018) Differential panel - Cerebral spinal fluid

5.17

21.72

1.2

—

(3026782) Osmolality of Urine

445

2845

1.77

21.71

4.3

2.9

mosm/kgh2o

560.0

547.8

0.60

381

2418

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

821

6195

1.65

21.45

6.6

6.0

mmol/l

1.2

0.06

715

5552

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

174

807

2.29

21.21

1.6

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

126

508

2.60

20.86

2.5

2.2

ug/l

326.7

634.7

1.20

111

475

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1012

11945

0.61

20.41

4.4

5.3

mmol/l

2.5

2.6

0.66

832

10763

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

8.51

20.16

2.3

1.1

nmol/l

84.1

135.8

0.65

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

875

6783

1.62

19.93

6.8

6.9

mmol/l

1.2

1.05

690

5690

(3023183) Ammonium ion [Moles/volume] in Plasma

258

3.21

19.91

1.9

2.7

umol/l

29.6

34.1

0.89

213

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

927

11150

0.62

19.91

3.5

4.2

mmol/l

1.2

1.3

0.58

747

9922

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

682

4996

1.62

19.46

4.9

3.4

—

(3030467) Casts [#/volume] in Urine by Automated count

557

3886

1.65

19.29

5.1

3.4

e6/l

0.4

0.5

1.51

445

2998

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

5.38

19.24

2.4

2.3

—

(36304419) Bacteria [Presence] in Urine

539

3736

1.66

19.11

5.2

3.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

289

1711

1.84

17.85

2.0

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

290

1728

1.82

17.51

2.0

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

488

3371

1.64

17.19

1.8

1.6

nmol/l

18.7

20.2

1.46

413

2811

(3024891) Influenza virus A+B Ag [Presence] in Specimen

287

2.92

17.17

1.4

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

12.26

16.93

3.1

2.0

umol/l

25.2

16.7

1.36

(3002582) Erythrocytes [#/volume] in Urine

585

4237

1.59

16.88

5.2

3.5

e6/l

41.7

91.0

1.90

470

3333

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

5.75

16.36

3.7

1.9

umol/l

74.1

49.8

1.96

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

4.31

16.02

1.2

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

4.76

15.91

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1055

8794

1.55

15.77

7.3

4.7

—

(3018418) pH of Serum or Plasma

557

4042

1.57

15.67

3.9

4.0

7.4

0.54

769

(3000850) Epithelial cells [#/volume] in Urine

441

3029

1.62

15.65

3.9

2.7

e6/l

4.7

5.0

0.28

389

2674

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

122

563

2.26

14.99

2.3

1.9

—

(1761868) Lipid panel - Serum or Plasma

209

3454

0.55

14.71

3.3

3.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

5.36

14.21

1.2

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

4.77

13.79

1.3

1.2

mmol/l

1.9

2.0

0.34

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

416

2897

1.58

13.66

1.8

1.7

pmol/l

417.0

12697484.1

1.50

316

2347

(3018095) Leukocytes [#/volume] in Urine

627

4804

1.49

13.14

5.9

3.9

e6/l

132.2

133.1

0.01

484

3546

(3012516) Albumin [Mass/volume] in Urine

278

4153

0.60

13.10

3.4

3.3

mg/l

292.2

251.7

0.06

174

2681

(3020682) Albumin/Creatinine [Ratio] in Urine

302

4401

0.62

12.76

4.2

4.0

mg/mmol

11.3

9.7

0.19

183

2815

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

173

964

1.89

12.76

2.0

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

730

5822

1.45

12.20

4.0

4.8

g/l

33.7

34.6

3.71

629

5384

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

201

3200

0.58

11.98

1.6

mmol/l

1.3

0.27

164

2631

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

123

623

2.05

11.94

2.4

2.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

332

2258

1.59

11.87

4.4

3.1

e6/l

3.9

2.0

1.83

190

1284

(3015377) Calcium [Moles/volume] in Serum or Plasma

577

4431

1.46

11.60

2.5

3.4

mmol/l

2.3

1.05

445

3769

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.06

11.48

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

168

962

1.83

11.35

2.0

1.6

1.7

1.5

1.47

137

810

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

634

4975

1.45

11.30

2.5

2.2

nmol/l

80.0

79.0

0.32

507

4318

(42870588) Differential panel, method unspecified - Blood

564

4330

1.46

11.28

8.0

5.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

493

3691

1.48

11.20

2.5

2.2

mg/l

2.9

3.1

1.33

376

3123

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

20.18

11.13

1.8

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

345

2399

1.55

11.13

4.2

2.9

e6/l

1.2

1.3

0.21

205

1421

(3012095) Magnesium [Moles/volume] in Serum or Plasma

319

2181

1.57

11.08

2.6

3.0

mmol/l

0.8

0.98

262

2031

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

3.81

11.05

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

4.06

10.96

1.8

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

232

1473

1.67

10.89

5.4

3.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

452

2.17

10.86

1.3

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.67

10.49

1.0

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

667

5340

1.42

10.40

5.5

4.2

ng/l

40.4

51.4

0.85

530

4084

(3036481) Cortisol [Moles/volume] in Serum or Plasma

177

1057

1.76

10.38

1.9

2.1

nmol/l

375.8

370.3

0.14

140

951

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1003

11317

0.71

9.90

6.3

6.5

mmol/mol

40.2

40.8

1.05

852

10277

(3009508) Creatinine [Moles/volume] in Urine

306

4242

0.66

9.73

3.3

3.2

mmol/l

7.2

0.09

233

3484

(3052851) Hemolysis interference index of Serum or Plasma

419

2.14

9.67

3.0

3.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

124

690

1.86

9.18

5.1

3.6

mmol/l

24.9

24.0

2.09

113

622

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

107

574

1.92

8.86

5.7

4.1

mmol/l

25.7

24.8

2.28

528

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1059

11762

0.72

8.71

4.6

5.0

mmol/l

6.0

6.1

0.18

868

10467

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

243

1654

1.55

8.47

10.4

8.1

—

(3035350) Ketones [Presence] in Urine by Test strip

724

6031

1.36

8.29

5.6

3.9

estimate

0.0

0.00

156

1161

(3014148) Varicella zoster virus Ab [Titer] in Serum

3.30

8.22

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

348

2569

1.45

8.14

3.1

3.0

mmol/l

2.5

0.00

276

2230

(3009261) Glucose [Presence] in Urine by Test strip

731

6121

1.35

7.99

5.7

4.0

estimate

0.0

0.50

161

1138

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

184

1190

1.61

7.97

2.7

2.4

u/l

38.3

36.7

0.11

147

1010

(3007853) Bacteria identified in Skin by Aerobe culture

225

1526

1.55

7.95

2.0

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

721

6034

1.35

7.88

7.6

5.4

estimate

0.0

0.50

158

1162

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

105

3.09

7.87

1.2

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

158

989

1.66

7.79

2.0

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

896

7759

1.34

7.71

6.3

4.8

mmol/l

6.6

6.8

3.32

838

7308

(3006653) Thiamine [Moles/volume] in Blood

3.93

7.44

1.2

1.1

nmol/l

128.2

134.6

0.28

(3029937) Albumin [Presence] in Urine by Test strip

428

3325

1.39

7.43

6.1

4.3

estimate

0.0

0.69

148

1099

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

20.11

7.13

1.8

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

3.46

7.13

2.6

1.9

e6/l

586.9

761.9

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

3.64

7.03

1.2

1.0

mg/l

29.2

42.9

1.08

(40761536) Microorganisms panel - Urine sediment

163

1069

1.58

6.66

7.4

4.2

—

(21494755) Public health laboratory ask at order entry panel

497

0.26

6.55

1.1

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.67

6.48

1.2

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

375

2915

1.37

6.36

4.8

3.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

6.70

6.31

2.1

2.5

—

(4027681)

3.86

6.26

1.6

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

140

903

1.60

6.15

4.9

3.8

mmol/l

2.3

2.0

0.41

106

672

(3014111) Lactate [Moles/volume] in Serum or Plasma

181

1245

1.51

5.98

7.0

6.6

mmol/l

1.3

1.4

1.37

170

1194

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

6.28

5.96

2.1

2.4

—

(3009343) pH of Capillary blood

143

939

1.57

5.83

5.0

3.9

7.4

1.74

112

(1001926) Buprenorphine [Presence] in Urine by Screen method

126

2.57

5.72

1.8

1.5

—

(3011288) Drugs identified in Urine by Screen method

103

2.75

5.70

2.7

2.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

144

953

1.56

5.68

4.9

3.9

kpa

5.3

5.2

1.04

127

881

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

575

0.36

5.66

1.6

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

197

1397

1.47

5.60

4.8

3.6

kpa

5.9

5.8

0.75

190

1350

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

687

5905

1.28

5.55

3.0

2.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

159

2.36

5.51

2.3

1.9

u/l

3660.9

2349.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

166

1141

1.51

5.51

4.8

2.9

kpa

4.4

4.5

0.33

159

1098

(3018010) Neutrophils/100 leukocytes in Blood

682

5864

1.28

5.47

8.8

5.7

61.6

58.6

8.28

611

5451

(3022096) Basophils/100 leukocytes in Blood

661

5662

1.28

5.46

9.2

5.8

0.6

2.54

590

5252

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1565

0.61

5.44

3.0

4.0

ug/l

8.9

25.7

1.38

1300

(3002032) Base excess in Venous blood by calculation

195

1388

1.46

5.44

4.9

3.6

mmol/l

2.5

2.0

1.09

167

1094

(3002030) Lymphocytes/100 leukocytes in Blood

691

5961

1.27

5.36

9.2

6.0

23.3

26.1

8.90

613

5505

(3033658) Prothrombin time (PT) actual/Normal

410

3316

1.31

5.22

4.4

4.0

85.3

84.1

0.39

395

3235

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

553

0.39

4.94

1.6

1.3

—

(3019069) Monocytes/100 leukocytes in Blood

676

5857

1.26

4.94

9.4

6.0

8.8

8.9

0.33

603

5447

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

120

1776

0.65

4.92

1.3

1.2

u/ml

4.7

13.9

2.62

632

(3006504) Eosinophils/100 leukocytes in Blood

673

5835

1.26

4.87

8.9

5.8

2.5

2.8

2.83

601

5403

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

175

1247

1.45

4.86

2.1

g/l

0.2

0.45

156

1159

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

230

3012

0.73

4.82

2.7

3.4

ug/l

0.7

0.8

0.66

158

2167

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

107

2.55

4.80

3.1

1.6

—

(3008295) Osmolality of Serum or Plasma

144

2.32

4.79

1.4

1.3

mosm/kgh2o

283.4

275.8

1.18

103

(3018677) aPTT in Platelet poor plasma by Coagulation assay

283

2196

1.35

4.76

2.1

2.0

29.6

30.2

1.04

272

2134

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

118

780

1.55

4.71

6.6

8.7

mmol/l

24.8

24.4

0.47

104

721

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

127

1840

0.66

4.69

1.3

1.2

iu/ml

51.9

37.5

0.26

579

(3003181) Sodium [Moles/volume] in Urine

261

1.94

4.62

1.6

1.3

mmol/l

62.9

61.4

0.08

212

(3003458) Phosphate [Moles/volume] in Serum or Plasma

246

1877

1.36

4.61

4.5

5.6

mmol/l

1.0

3.03

205

1739

(3013115) Eosinophils [#/volume] in Blood

724

6364

1.25

4.55

9.4

5.7

e9/l

0.2

5.84

618

5520

(3012501) Base excess in Blood by calculation

313

1.85

4.53

4.1

4.8

mmol/l

1.9

2.9

2.45

212

(3019198) Lymphocytes [#/volume] in Blood

716

6292

1.24

4.49

8.6

5.6

e9/l

1.6

1.9

5.88

615

5462

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

540

4604

1.26

4.41

6.4

4.3

—

(3016879) Cocaine [Presence] in Urine

151

2.21

4.32

1.8

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

239

1837

1.35

4.27

2.0

2.5

1.6

1.8

2.57

177

1613

(3001604) Monocytes [#/volume] in Blood

698

6141

1.24

4.26

8.5

5.5

e9/l

0.6

0.49

590

5215

(3051651) Icteric interference index of Serum or Plasma

2.61

4.14

2.5

3.1

—

(3006315) Basophils [#/volume] in Blood

699

6166

1.23

4.13

8.5

5.5

e9/l

0.0

2.47

593

5253

(3022313) Gas panel - Capillary blood

105

703

1.53

3.99

5.6

3.9

—

(3019225) pH of Specimen

191

1434

1.38

3.96

5.1

4.7

—

(3010421) pH of Blood

374

1.71

3.90

4.3

4.4

7.4

0.04

309

(3000764) Benzodiazepines [Presence] in Urine

158

2.11

3.89

1.9

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

132

2.22

3.87

1.1

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

139

2.18

3.84

1.1

1.7

—

(3027008) Opiates [Presence] in Urine

159

2.10

3.83

1.9

1.5

—

(1616796) Gas panel - Central venous blood

316

1.77

3.82

2.3

3.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

6.03

3.81

1.2

1.0

—

(40758558) Short blood count panel - Blood

379

3147

1.27

3.81

9.9

6.6

—

(40768804) Tissue Pathology biopsy report

429

5029

0.80

3.76

2.2

2.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

288

3537

0.78

3.75

2.3

2.9

umol/l

7321.8

7714.8

0.04

212

2987

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

766

6867

1.22

3.74

5.0

6.2

umol/l

10.9

12.4

3.53

688

6508

(3028300) Cannabinoids [Presence] in Urine

161

2.07

3.72

1.9

1.5

—

(3032080) INR in Blood by Coagulation assay

669

5920

1.22

3.72

9.8

11.3

inr

1.3

1.4

1.57

171

1608

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

641

1.53

3.71

2.3

1.9

ug/l

2.3

0.01

563

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

217

1679

1.34

3.71

6.2

6.8

kpa

5.1

0.09

199

1580

(3027801) Oxygen [Partial pressure] in Arterial blood

217

1680

1.34

3.70

6.2

6.8

kpa

11.8

11.9

0.19

197

1583

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

389

0.38

3.69

1.3

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

181

1363

1.37

3.69

2.7

2.5

ug/l

5.7

6.7

0.41

1186

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1044

0.62

3.68

2.7

3.2

ml/min/173m2

72.7

58.9

1.63

462

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

155

2.09

3.68

2.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.55

3.63

1.4

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.55

3.63

1.4

1.2

—

(3003396) Base excess in Arterial blood by calculation

217

1685

1.33

3.62

6.3

6.8

mmol/l

1.3

1.2

0.14

171

1288

(40768800) Prostate Pathology biopsy report

366

0.38

3.52

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

229

1.86

3.48

4.6

3.3

e9/l

3.7

4.5

1.50

229

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

106

2.28

3.46

1.4

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

106

2.28

3.46

1.4

1.3

—

(3024928) Oxygen saturation in Venous blood

304

1.73

3.44

6.8

2.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

440

3755

1.23

3.43

3.2

3.1

u/l

34.7

34.9

0.02

398

3552

(3019150) Specific gravity of Urine by Refractometry

325

2681

1.26

3.43

5.5

4.3

kg/l

1.0

1.64

422

(3011412) CD3 cells [#/volume] in Blood

2.36

3.41

2.7

2.0

e9/l

1.3

1.1

0.55

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

203

1.89

3.36

1.8

2.4

mg/l

30.0

26.4

—

(3022145) Colonoscopy Study observation

1336

0.68

3.32

1.3

—

(3044889) 12 lead EKG panel

804

8787

0.83

3.31

4.2

4.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

169

1.97

3.30

2.5

4.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1059

11286

0.83

3.28

23.6

16.2

ml/min/173m2

80.8

73.1

23.75

881

9369

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

468

4040

1.22

3.25

2.6

2.5

u/l

53.8

57.9

1.18

413

3698

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.17

3.21

1.1

miu/ml

1459.5

1643.5

0.19

(3025941) Bacteria identified in Stool by Culture

589

1.50

3.20

1.4

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

961

8881

1.20

3.18

4.8

3.9

pmol/l

14.9

15.0

0.52

807

7906

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

626

1.48

3.10

2.9

3.2

pmol/l

4.4

0.08

542

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

239

1.78

3.07

4.6

3.7

59.3

59.7

0.09

239

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.69

3.06

1.4

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.69

3.06

1.4

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.02

3.05

1.0

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.02

3.05

1.0

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

516

1.52

2.99

1.5

—

(3028433) Virus identified in Specimen by Culture

3.01

2.97

1.2

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.72

2.92

1.0

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.35

2.91

1.1

1.2

—

(4094501)

305

0.39

2.89

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.60

2.87

1.5

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

483

4231

1.20

2.83

2.5

2.6

—

(3006270) Folate [Moles/volume] in Blood

123

2.05

2.82

1.3

1.2

nmol/l

341.3

352.9

0.08

(3000991) Gas panel - Venous blood

157

1212

1.33

2.76

8.0

7.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

8.35

2.75

1.8

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.02

2.73

1.1

—

(40761535) Cells panel - Urine sediment

150

1153

1.33

2.72

3.6

—

(3027944) Amphetamines [Presence] in Urine

160

1.89

2.72

2.0

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

153

1.91

2.71

3.0

3.2

—

(3051593) INR in Capillary blood by Coagulation assay

2.25

2.70

4.8

19.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1212

12683

0.83

2.69

12.8

11.2

u/l

21.2

24.7

6.51

1101

12129

(4035726)

1167

0.70

2.67

1.3

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

838

0.64

2.66

1.6

2.2

nmol/l

13.2

11.8

0.50

721

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

363

4201

0.83

2.65

4.0

4.9

20.2

22.0

1.55

175

2220

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

2.40

2.63

2.1

13.5

16.4

—

(4024509)

127

1.98

2.61

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.31

2.58

1.9

2.1

—

(3020491) Glucose [Moles/volume] in Blood

101

2.09

2.53

2.1

2.6

mmol/l

8.0

7.3

0.24

(3032057) Clostridioides difficile [Presence] in Stool

3.04

2.53

1.6

1.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1048

9855

1.17

2.52

7.5

7.7

u/l

82.4

81.3

0.25

925

9204

(3003694) ABO and Rh group [Type] in Blood

257

3063

0.81

2.51

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

142

1097

1.32

2.50

1.6

2.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

580

5209

1.17

2.49

3.1

2.9

ug/l

130.9

147.7

1.04

471

4718

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1151

0.71

2.49

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1258

12021

1.19

2.47

26.3

16.8

mg/l

29.3

26.7

1.84

1098

9794

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

180

1440

1.28

2.45

2.2

2.7

umol/l

8.1

9.7

0.51

148

1257

(3013650) Neutrophils [#/volume] in Blood by Automated count

780

7178

1.16

2.45

11.3

8.8

e9/l

4.5

4.3

1.99

669

6226

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

273

1.63

2.42

1.4

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1244

0.72

2.38

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

777

7164

1.16

2.35

4.2

3.1

u/l

65.0

54.5

0.93

686

6544

(40768793) Breast Pathology biopsy report

263

0.41

2.34

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.63

2.27

1.0

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.57

2.21

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.25

2.18

2.4

2.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

333

0.51

2.14

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

182

1.72

2.12

1.7

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

182

1.72

2.12

1.7

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

481

1.43

2.10

1.7

2.4

g/l

37.7

36.9

0.48

410

(3005988) Vibrio sp identified in Specimen by Organism specific culture

183

1.71

2.08

1.7

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.91

2.07

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.91

2.07

1.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

184

1.70

2.05

1.7

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

116

899

1.31

2.04

3.4

2.8

g/l

9.7

10.9

2.43

101

813

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

185

1.69

2.01

1.7

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.51

2.01

1.4

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

108

1387

0.76

2.00

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

164

1.72

1.95

1.4

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

4.56

1.94

1.0

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

242

1.58

1.93

1.3

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

159

1293

1.25

1.93

1.5

2.7

g/l

65.9

66.2

0.21

129

1171

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.74

1.93

3.2

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.74

1.93

1.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.74

1.93

1.0

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

364

1.47

1.92

1.4

1.5

ug/g

273.4

262.7

0.15

213

(3028271) Lactate [Moles/volume] in Capillary blood

236

1.58

1.88

2.1

2.0

mmol/l

2.1

1.6

0.59

229

(3047007) Chlamydophila sp Ab [Presence] in Serum

142

0.35

1.88

1.4

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

174

1.68

1.86

6.2

8.3

mmol/l

8.1

7.2

0.76

149

(3021879) Hepatitis B virus core Ab [Presence] in Serum

665

1.34

1.86

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

142

1145

1.26

1.86

4.5

3.7

mmol/l

1.2

0.11

115

993

(3004789) Transferrin [Mass/volume] in Serum or Plasma

248

2121

1.20

1.86

2.2

2.6

g/l

2.2

2.3

1.97

192

1953

(3022948) Iron [Moles/volume] in Serum or Plasma

265

2281

1.19

1.85

2.3

2.6

umol/l

11.4

12.2

1.12

214

2104

(3000492) Spirometry study

991

0.73

1.85

1.4

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.54

1.84

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

183

1.65

1.82

1.7

1.3

—

(3019060) Gas panel - Arterial blood

123

978

1.28

1.81

4.8

4.3

—

(3016502) Oxygen saturation in Arterial blood

181

1505

1.23

1.81

6.5

7.1

95.5

95.3

0.18

172

1440

(3023520) Reticulocytes [#/volume] in Blood

167

1377

1.24

1.81

1.8

2.5

e9/l

60.8

68.9

3.03

121

1074

(3002619) Bacteria identified in Specimen by Culture

3.05

1.80

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

301

2631

1.18

1.76

1.8

1.6

mg/l

1.5

1.4

0.04

222

2056

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

338

1.46

1.76

2.0

1.6

iu/ml

0.3

0.06

(3041096) Erythrocytes [Presence] in Urine by Automated

358

3174

1.16

1.75

6.1

3.8

—

(3025130) Human papilloma virus identified in Specimen

2.04

1.75

1.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

127

1021

1.26

1.72

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.96

1.69

1.6

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

210

1789

1.20

1.66

7.8

6.5

mmol/l

104.5

104.2

0.43

204

1741

(4010399)

914

0.74

1.63

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

205

1.57

1.63

2.9

2.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.15

1.61

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.51

1.59

1.0

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.59

1.4

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.59

1.4

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.59

1.4

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.59

1.4

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

306

1.45

1.55

1.9

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

770

0.73

1.54

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

563

1.33

1.54

2.0

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

284

0.56

1.54

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

425

1.38

1.53

6.0

3.7

mmol/l

3.9

0.13

387

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

249

1.50

1.53

2.4

1.7

iu/l

3.6

5.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

130

1.70

1.53

1.4

1.1

u/l

62.4

52.2

0.34

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.34

1.52

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.34

1.52

1.0

1.1

100.0

95.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

316

1.44

1.51

1.3

1.6

—

(4198724)

2.86

1.50

1.8

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.86

1.50

1.2

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

522

1.34

1.50

1.8

2.7

g/l

0.7

1.5

1.19

442

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

475

5177

0.88

1.49

4.2

5.7

ug/l

2.8

4.5

1.20

377

4576

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

428

1.37

1.48

1.8

2.5

g/l

0.0

0.00

387

(3028192) IgG subclass 2 [Mass/volume] in Serum

1.80

1.43

1.2

g/l

2.9

2.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

1.80

1.43

1.2

g/l

7.5

7.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

1.80

1.43

1.2

g/l

0.4

—

(40767503) Oxygen content in Capillary blood by calculation

312

1.42

2.5

2.6

16.7

15.5

0.91

160

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

251

0.55

1.41

1.0

1.2

—

(3008898) HLA-B27 [Presence]

300

0.60

1.39

1.0

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

425

1.35

1.38

1.9

2.5

g/l

0.0

0.00

387

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

331

1.40

1.38

1.3

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

452

1.34

1.36

1.8

2.5

g/l

0.0

1.44

409

(3009542) Hematocrit [Volume Fraction] of Blood

1084

10420

1.12

1.36

29.0

18.4

37.8

38.4

1.27

607

6610

(21494890) Protein electrophoresis panel - 24 hour Urine

165

0.48

1.35

2.0

2.2

—

(4062490)

1.76

1.35

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

297

0.60

1.35

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

228

1999

1.16

1.31

2.5

2.6

21.1

21.9

0.37

172

1703

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.51

1.30

1.2

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

129

1077

1.21

1.30

3.4

4.1

ng/l

92.4

99.1

0.22

937

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.01

1.27

2.4

2.1

u/ml

1105.0

1269.8

0.12

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

511

1.30

1.26

1.8

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.01

1.23

1.1

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

348

1.36

1.22

4.6

3.3

mmol/l

1.8

1.6

0.40

342

(3024869) Neuronal Ab [Presence] in Serum

2.64

1.21

1.0

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

159

1367

1.18

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

307

2773

1.13

1.17

4.0

4.2

ng/l

131.7

343.1

2.14

265

2387

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

377

1.34

1.16

1.5

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

572

1.27

1.15

1.7

2.5

g/l

3.1

3.2

0.42

453

(3017732) Neutrophils [#/volume] in Blood

807

1.23

1.15

4.0

2.9

e9/l

4.0

4.1

0.22

588

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

112

0.44

1.13

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

112

0.44

1.13

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

112

0.44

1.13

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

112

0.44

1.13

1.2

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

319

1.36

1.12

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

701

1.24

1.11

2.6

2.4

—

14.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

137

0.51

1.09

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

144

1.53

1.09

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

321

1.35

1.08

1.2

—

(21494434) Karyotype in Bone marrow

165

0.54

1.08

1.0

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

325

0.67

1.05

1.2

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

229

0.61

1.05

3.6

2.7

—

(3037121) Protein [Mass/volume] in Urine

517

1.27

1.05

2.8

3.0

g/l

0.5

0.3

0.47

208

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

191

0.57

1.04

1.0

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1123

10884

1.10

1.04

5.9

4.7

mu/l

2.0

2.1

0.40

951

9724

(42529406) Shigella sp [Presence] in Stool by Culture

324

1.34

1.03

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

151

0.53

1.03

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

106

1.61

1.03

1.2

1.6

—

(3045424) Erythrocytes [Presence] in Urine

188

1.44

1.01

1.6

1.4

—

(3002256) Pathology report gross observation

147

1687

0.86

1.00

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

239

2148

1.13

1.00

22.9

30.9

inr

1.6

1.5

0.20

286

(21494814) CD8 cells/100 lymphocytes in Specimen

2.00

1.00

1.9

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

355

3266

1.11

0.99

2.4

—

(3010813) Leukocytes [#/volume] in Blood

1280

13088

0.90

0.99

36.4

24.9

e9/l

6.9

0.01

1214

12623

(3027456) Digoxin [Moles/volume] in Serum or Plasma

435

0.73

0.98

4.3

3.2

nmol/l

0.7

0.8

1.45

338

(3026361) Erythrocytes [#/volume] in Blood

1280

13085

0.90

0.97

36.4

24.9

e12/l

4.3

4.4

20.09

1216

12630

(3035941) MCH [Entitic mass]

1280

13084

0.90

0.96

36.2

24.8

30.5

30.4

0.56

1225

12823

(3024731) MCV [Entitic volume]

1280

13084

0.90

0.96

36.3

24.8

92.0

91.6

2.41

1225

12824

(3036782) Glucose [Moles/volume] in Pleural fluid

186

0.59

0.96

1.0

1.4

mmol/l

5.2

6.5

0.83

174

(3007461) Platelets [#/volume] in Blood

1280

13082

0.90

0.95

36.4

24.9

e9/l

241.7

240.9

0.15

1216

12667

(3028026) IgM [Mass/volume] in Serum or Plasma

734

1.21

0.95

2.4

1.8

g/l

2.1

1.6

0.54

664

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

116

0.52

0.94

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

116

0.52

0.94

1.2

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

580

1.23

0.94

1.7

2.5

g/l

9.5

10.6

1.34

491

(3000963) Hemoglobin [Mass/volume] in Blood

1281

13087

0.91

0.93

36.7

25.0

g/l

128.3

132.7

21.09

1225

12841

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

536

1.24

0.92

1.9

3.5

mg/l

31.5

80.3

1.28

447

(3034860) Kappa light chains.free [Mass/volume] in Serum

537

1.24

0.91

1.9

3.5

mg/l

81.3

66.3

0.21

445

(44813793)

1.75

0.90

1.0

—

(3044927) Protein electrophoresis panel - Urine

185

1.41

0.89

1.4

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.07

0.89

1.5

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

768

1.20

0.88

1.4

1.8

g/l

1.5

0.02

659

(3005322) IgE [Units/volume] in Serum or Plasma

592

0.79

0.86

1.6

1.2

u/ml

226.8

208.8

0.05

534

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

192

1722

1.13

0.85

2.1

3.9

u/l

223.3

250.8

2.88

163

1626

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

615

1.21

0.85

1.7

2.5

g/l

4.0

3.8

0.20

441

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

616

1.21

0.84

1.7

2.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

188

1.39

0.83

1.2

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

617

1.21

0.83

1.7

2.5

g/l

7.0

7.5

1.25

459

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.74

0.82

1.0

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

302

1.30

0.81

1.6

1.3

—

(3042936) Bacteria identified in Isolate by Culture

216

1958

1.12

0.81

1.9

2.0

—

(40768797) Stomach Pathology biopsy report

156

1751

0.88

0.81

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

130

1.47

0.81

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

130

1.47

0.81

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

130

1.47

0.81

1.4

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

131

1.46

0.78

1.5

1.4

—

(3017704) Immunofixation for Urine

0.52

0.78

1.0

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.51

0.78

1.2

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

349

0.74

0.77

1.5

2.4

ug/min

134.7

78.2

—

216

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.77

0.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.77

0.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.77

0.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.77

0.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

126

0.55

0.77

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

198

0.65

0.77

1.2

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

157

1.41

0.76

1.2

1.5

g/l

0.5

0.8

1.50

119

(3000093) Morphology [Interpretation] in Blood Narrative

133

1.43

0.73

1.1

1.2

—

(3021589) Normoblasts [#/volume] in Blood

569

5421

1.08

0.72

14.2

10.1

e9/l

0.0

2.28

466

4396

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

107

0.56

0.72

1.0

1.2

nmol/l

1.0

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

195

0.66

0.72

1.2

miu/ml

203.8

236.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

171

0.64

0.72

1.7

1.2

—

(3022621) pH of Urine by Test strip

103

898

1.16

0.71

4.3

3.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

133

1181

1.14

0.71

1.5

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

247

2275

1.10

0.70

1.3

1.2

u/ml

0.8

1.6

2.61

573

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

152

1.39

0.69

1.2

1.6

—

(3021788) Differential panel - Synovial fluid

257

1.29

0.69

1.7

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.56

0.68

2.1

1.5

u/l

1.2

9.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.64

0.68

1.0

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.53

0.68

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.53

0.68

1.1

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

214

1.31

0.67

1.9

1.2

—

(3005033) Fetal Nuchal fold Thickness US

0.54

0.67

1.2

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.54

0.67

1.2

1.4

—

(4015189)

1.63

0.67

1.1

2.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

403

1.22

0.66

1.8

3.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1.52

0.66

1.2

1.4

u/l

29.5

29.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.59

0.65

1.9

2.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

189

0.69

0.64

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

938

9634

0.94

0.62

30.8

20.6

13.8

13.9

1.92

900

9392

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

288

1.26

0.62

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

388

1.22

0.62

1.4

1.2

u/ml

0.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.55

0.62

1.2

1.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.50

0.59

1.3

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

299

0.77

0.59

1.3

1.2

u/ml

30.2

11.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.45

0.59

6.4

2.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

116

0.60

0.57

1.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

149

0.67

0.56

1.0

1.1

—

13.1

—

(3037522) Nuclear Ab [Titer] in Serum

131

1444

0.90

0.55

1.5

1.3

titre

446.1

551.7

0.42

329

(3050129) First trimester maternal screen panel - Serum or Plasma

122

0.65

0.54

1.5

—

(3004451) EKG impression Narrative

1.47

0.54

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.58

0.54

1.7

1.2

—

(3037756) Immunofixation for Serum or Plasma

361

0.80

0.54

1.2

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

204

1.28

0.54

1.2

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

250

0.76

0.54

1.6

1.3

—

(3000012) Reticulocyte production index

1.49

0.53

1.6

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

676

1.15

0.53

5.4

4.0

49.4

47.5

0.27

667

(3007164) IgA [Mass/volume] in Serum or Plasma

224

2088

1.08

0.52

1.6

1.4

g/l

2.4

2.6

0.78

118

1215

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.41

0.51

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

261

1.23

0.50

1.6

1.8

—

(3003338) MCHC [Mass/volume]

934

9552

0.95

0.49

32.1

22.5

g/l

330.3

331.3

2.16

893

9453

(3023323) Follitropin [Units/volume] in Serum or Plasma

244

1.23

0.48

1.7

1.4

iu/l

25.6

27.2

0.10

210

(3044941) Cell count panel - Synovial fluid

217

1.25

0.48

1.6

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

182

1.27

0.46

1.2

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.46

1.7

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.46

1.7

2.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

582

6017

0.95

0.46

3.8

4.3

—

(1002224) Polysomnography panel

301

1.20

0.45

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

121

0.66

0.45

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.40

0.45

1.1

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.45

0.44

1.1

1.2

—

(3020891) Body temperature

555

1.14

0.43

7.4

4.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

174

0.75

0.43

1.5

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.41

0.43

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.41

0.43

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.41

0.43

1.3

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

230

1.22

0.42

1.2

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.56

0.42

3.2

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.56

0.42

1.2

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

194

1.24

0.42

1.3

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.52

0.41

1.4

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.2

—

154.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.41

0.0

2.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.40

0.40

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.40

0.40

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.40

0.40

1.3

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.4

—

11.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.6

—

52.6

—

(3045788) Cell count panel - Pleural fluid

183

0.76

0.40

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

324

1.18

0.40

1.9

2.2

g/l

129.8

124.9

0.60

233

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

186

1.24

0.40

1.2

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

238

0.80

0.40

1.1

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

227

0.79

0.40

1.9

1.4

nmol/l

0.4

0.8

2.42

178

(3048689) Calprotectin [Mass/mass] in Stool

127

1176

1.09

0.38

1.8

2.0

ug/g

195.7

142.5

0.88

893

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.35

0.38

1.2

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

236

2487

0.94

0.37

6.0

4.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

687

1.11

0.37

6.3

2.4

1.3

1.1

0.60

681

(3010144) Erythrocytes [#/volume] in Synovial fluid

125

1.28

0.37

1.2

1.3

e6/l

10774.4

153743.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.39

0.37

1.2

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

113

1044

1.09

0.36

3.8

4.2

0.0

0.1

1.18

328

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.66

0.35

1.0

1.5

—

73.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.32

0.35

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.37

0.34

1.2

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

107

989

1.09

0.34

3.4

4.0

1.1

0.6

0.47

248

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

519

0.88

0.33

2.3

2.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

435

1.13

0.33

1.3

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.67

0.33

1.5

3.7

—

(3004616) Nuclear Ab [Presence] in Serum

146

1.24

0.32

1.1

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

252

0.83

0.32

1.3

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.73

0.31

1.0

—

(3045414) Leukocytes [Presence] in Urine

552

1.11

0.31

1.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

419

1.13

0.30

8.2

4.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

334

1.14

0.30

1.8

1.6

e6/l

15568.9

16745.6

0.08

237

(3045142) Bone marrow Pathology biopsy report

163

0.80

0.29

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

141

0.78

0.29

1.4

2.3

—

(4281824)

128

0.78

0.27

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

193

0.83

0.26

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

182

0.82

0.26

2.3

2.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

138

0.80

0.25

1.3

—

(3025159) Blasts/100 leukocytes in Blood

103

967

1.07

0.25

3.9

4.2

0.0

0.4

0.70

269

(4268621)

1.25

0.24

2.2

2.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.72

0.24

4.2

3.5

—

(3011985) Renin [Units/volume] in Plasma

152

1.19

0.23

1.3

mu/l

77.6

46.6

0.34

131

(3005570) Glucose [Moles/volume] in Urine

134

1.20

0.23

1.5

1.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

210

0.86

0.22

1.3

e6/l

107157.5

65170.8

0.30

125

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.22

0.22

1.4

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

315

0.89

0.21

2.3

—

(3025315) Body weight

0.00

0.21

0.0

3.5

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3017181) Myelocytes/100 leukocytes in Blood

117

1111

1.06

0.21

3.8

4.1

0.7

0.9

0.34

359

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

450

0.91

0.21

1.1

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

145

1.17

0.20

1.1

1.2

u/ml

1.8

3.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.20

0.0

5.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.2

—

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.20

0.0

1.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

489

0.92

0.19

1.2

1.9

u/l

34.2

38.7

0.78

419

(40768806) Pleura Pathology biopsy report

207

0.87

0.19

1.3

1.6

—

(3024263) Appearance of Synovial fluid

1.24

0.18

1.3

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

238

0.88

0.18

15.0

2.2

55.6

61.6

0.62

238

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

137

1428

0.96

0.18

2.2

3.1

ng/l

245.9

269.7

0.27

123

1303

(3009445) Proteinase 3 Ab [Units/volume] in Serum

561

1.07

0.18

1.2

1.4

—

8.0

—

(4146454)

157

1.15

0.17

2.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

773

0.94

0.17

3.6

2.8

e6/l

0.8

0.3

0.73

756

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

152

0.85

0.17

2.3

1.6

—

(40761511) CBC panel - Blood by Automated count

1238

12303

1.02

0.15

23.4

16.2

—

(3013512) EKG study

417

4097

1.02

0.15

4.9

4.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.10

0.15

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.10

0.15

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

352

1.08

0.15

5.2

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.79

0.14

1.0

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1271

12640

1.02

0.14

29.7

20.2

mmol/l

139.5

0.19

1216

12282

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

112

1.16

0.14

1.8

1.5

u/ml

23.6

26.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

160

1.13

0.14

1.7

1.5

71.6

64.7

—

106

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

141

1.14

0.14

1.3

1.2

nmol/l

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

402

1.07

0.14

1.8

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

137

1325

1.04

0.13

4.4

6.8

mmol/l

10.0

11.4

1.45

118

1263

(3003740) Influenza virus B Ag [Presence] in Specimen

0.82

0.13

1.3

1.1

—

(4306422)

138

0.87

0.13

1.0

1.2

—

(3035880) pH of Pleural fluid

109

0.82

0.13

1.0

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1272

12659

1.02

0.12

29.6

20.4

mmol/l

4.0

7.99

1216

12283

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

137

0.88

0.12

1.0

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

259

1.08

0.11

1.1

1.2

—

24.0

—

(36660697) Celiac disease serology panel - Serum

812

0.96

0.11

1.4

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

136

0.88

0.11

1.0

1.1

104.9

114.3

0.37

124

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.09

0.09

1.2

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.11

0.09

1.7

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.09

0.09

1.0

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

204

1.08

0.08

1.1

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

400

1.05

0.08

1.5

1.6

—

(3023383) Lactate [Moles/volume] in Pleural fluid

0.82

0.08

1.2

1.4

mmol/l

6.3

3.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.77

0.08

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

166

1.09

0.07

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.82

0.07

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

174

0.92

0.07

2.4

3.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

629

1.03

0.07

1.2

iu/ml

172.5

132.6

0.25

230

(3017569) Oxygen content in Arterial blood

1.03

0.07

1.1

2.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

580

1.04

0.07

5.9

2.5

u/ml

0.4

0.58

336

(44790047)

153

0.91

0.07

1.3

1.5

—

(44790049)

153

0.91

0.07

1.3

1.5

—

(44790048)

153

0.91

0.07

1.3

1.5

—

(44806118)

153

0.91

0.07

1.3

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.84

0.07

1.4

1.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

1.12

0.07

1.0

1.1

—

88.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

101

0.89

0.06

1.0

1.1

—

42.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

925

9215

1.01

0.05

4.3

4.2

mm/h

14.0

14.5

0.47

801

8425

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

783

1.02

0.05

2.6

2.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

470

4729

0.99

0.04

3.1

3.2

ng/l

1438.1

1858.4

1.47

377

4120

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.10

0.04

1.1

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

167

1687

0.99

0.03

3.8

4.7

36.0

33.1

1.73

1091

(3049717) Cytology report of Urine Cyto stain

662

0.98

0.03

2.4

2.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

209

0.96

0.03

1.2

1.4

—

(3000330) Specific gravity of Urine by Test strip

762

0.98

0.03

6.2

3.8

—

(3000494) Fungus identified in Specimen by Culture

143

1442

0.99

0.02

1.5

1.4

—

(40768443) Skin Pathology biopsy report

571

1.02

0.02

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

197

0.96

0.01

1.2

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

213

1.03

0.01

1.1

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

277

0.97

0.01

1.6

1.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

104

1.06

0.01

1.5

1.4

titre

78.0

355.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

144

1.04

0.00

1.1

1.2

u/ml

1.6

5.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

186

0.97

0.00

1.0

1.4

u/ml

76.1

116.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

204

1.03

0.00

1.2

1.3

u/l

17.7

10.2

0.69

159

(3042631) Mycobacterium sp identified in Specimen

216

0.97

0.00

2.3

2.6

—

(3025577) Chromium [Mass/volume] in Blood

1.01

0.00

2.0

2.1

ug/l

0.9

2.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.01

0.00

1.1

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

104

0.96

0.00

1.1

1.3

—

(3011648) Oxygen content in Venous blood

114

0.96

0.00

1.4

1.7

8.7

10.7

1.04

114

(3016650) Hepatitis A virus Ab [Presence] in Serum

162

0.99

0.00

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

318

1.01

0.00

6.1

3.8

mg/l

26.1

30.3

0.31

200

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

191

0.99

0.00

1.1

1.3

u/ml

384.9

294.4

—

109

(3048929) Epstein Barr virus Ab [Presence] in Serum

279

1.00

0.00

1.2

1.3

—

(3021901) Oxygen saturation in Capillary blood

299

1.00

0.00

2.2

3.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

379

1.00

0.00

1.5

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

102

0.98

0.00

2.2

2.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

103

0.97

0.00

1.0

1.1

95.6

96.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

147

1.02

0.00

1.3

1.2

—

(4034850)

393

0.99

0.00

11.1

10.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

777

1.00

0.00

7.8

9.3

—

(40765096) Chromosome analysis panel by Banding

0.89

0.00

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.01

0.00

1.4

2.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.0

5.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.0

2.6

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

10.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.0

1.8

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.0

—

7.8

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.8

—

17.8

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.95

0.00

1.3

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.95

0.00

1.3

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.02

0.00

1.0

1.1

iu/ml

83.2

216.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

160

1.00

0.00

1.3

1.2

nmol/l

0.3

0.6

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

2.3

—

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.93

0.00

1.2

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

3.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.90

0.00

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

3.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.0

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.8

—

(40768441) Liver Pathology biopsy report

0.91

0.00

1.0

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.2

—

(3013466) aPTT in Blood by Coagulation assay

0.00

0.0

1.0

—

33.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

6.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.0

5.2

—

0.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

230

1.00

0.00

1.3

1.4

e6/l

1298.8

1422.6

0.13

167

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_DEMINOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_DEMINOTH	3.646 [3.25, 4.09]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.076

During the follow-up period (1.1.1998 — 31.12.2019), 5126 out of 8279 females with F5_DEMINOTH died.

Males

Parameter	HR [95% CI]	p-value
F5_DEMINOTH	4.383 [3.76, 5.1]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 5757 out of 8363 males with F5_DEMINOTH died.

Mortality risk

Mortality risk for people of age

years, who have F5_DEMINOTH.

N-year risk	Females	Males
1	0.309%	0.759%
5	2.253%	4.983%
10	5.472%	11.813%
15	9.863%	22.234%
20	16.123%	34.978%

Relationships between endpoints

↥

Index endpoint: F5_DEMINOTH – Dementia in other diseases classified elsewhere

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dementia in other diseases classified elsewhere

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints